Similarly, IL-15/IL-15Rα has been included in iPSC-derived CAR-NK cells against MM (FT576) (102) or B cell malignancies (FT596) (103), being the latter under assessment in a phase I clinical trial (NCT04245722) (37). The gene discussed is IL15; the disease is Miyoshi myopathy.